Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elisabeth Ralfkiær
Molecular Monitoring After Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results From the Nordic Mantle Cell Lymphoma Studies (MCL2 and McL3) With Median Follow-Up of 8.5 Years
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Efficacy of Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A 3-Year Follow-Up Study
Bone Marrow Transplantation
Transplantation
Hematology
Prognostic Variables of Progression Free Survival in Mantle Cell Lymphoma After Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Haematopoietic Stem Cell Transplantation for Behcet's Disease With Pulmonary Involvement: Analysis After 5 Years of Follow Up
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Evolution of Clonal Hematopoiesis in Mantle Cell Lymphoma Patients Before, During, and After Induction Chemotherapy and Autologous Stem Cell Transplantation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Treatment Pathways and Resource Use Associated With Recurrent Hodgkin Lymphoma After Autologous Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply
The Lancet Oncology
Oncology
Rituximab-Related Late-Onset Neutropenia After Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Bortezomib Maintenance After R-Chop, Cytarabine and Autologous Stem Cell Transplantation in Newly Diagnosed Patients With Mantle Cell Lymphoma, Results of a Randomised Phase II HOVON Trial
British Journal of Haematology
Hematology
